top of page

Montai Health's CEO talks about using AI to develop small molecules at #HLTH2023

Margo Georgiadis describes how Montai is trying to harness anthromolecule chemistry to tackle disease, lesson's learned from the AI ambition of companies that have come before, and how tailoring molecules in a hyperspecific way might avoid one of the big pitfalls of the Inflation Reduction Act.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page